Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2041-1723

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer ; volume:9 ; number:1 ; day:2 ; month:11 ; year:2018 ; pages:1-11 ; date:12.2018
Nature Communications ; 9, Heft 1 (2.11.2018), 1-11, 12.2018

Creator: Caetano, Mauricio S.
Hassane, Maya
Van, Hieu T.
Bugarin, Emmanuel
Cumpian, Amber M.
McDowell, Christina L.
Cavazos, Carolina Gonzalez
Zhang, Huiyuan
Deng, Shanshan
Diao, Lixia
Wang, Jing
Evans, Scott E.
Behrens, Carmen
Wistuba, Ignacio I.
Fuqua, Susan A. W.
Lin, Huang
Stabile, Laura P.
Watowich, Stephanie S.
Kadara, Humam
Moghaddam, Seyed Javad

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41467-018-07042-y

URN: urn:nbn:de:101:1-2018121721334477993035

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Caetano, Mauricio S.
Hassane, Maya
Van, Hieu T.
Bugarin, Emmanuel
Cumpian, Amber M.
McDowell, Christina L.
Cavazos, Carolina Gonzalez
Zhang, Huiyuan
Deng, Shanshan
Diao, Lixia
Wang, Jing
Evans, Scott E.
Behrens, Carmen
Wistuba, Ignacio I.
Fuqua, Susan A. W.
Lin, Huang
Stabile, Laura P.
Watowich, Stephanie S.
Kadara, Humam
Moghaddam, Seyed Javad
SpringerLink (Online service)

Other Objects (12)

Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression

Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Target Mutant KRAS with Molecular Glue

K-Ras protein as a drug target

Unraveling (K)RAS in pancreatic ductal adenocarcinoma

A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

A pan-KRAS degrader for the treatment of KRAS-mutant cancers

Current therapy of KRAS-mutant lung cancer

A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers

Hochschulschrift

Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer

Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression

Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Target Mutant KRAS with Molecular Glue

K-Ras protein as a drug target

Unraveling (K)RAS in pancreatic ductal adenocarcinoma

A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

A pan-KRAS degrader for the treatment of KRAS-mutant cancers

Current therapy of KRAS-mutant lung cancer

A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers

Hochschulschrift

Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer

Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression

Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Target Mutant KRAS with Molecular Glue

K-Ras protein as a drug target

Unraveling (K)RAS in pancreatic ductal adenocarcinoma

A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

A pan-KRAS degrader for the treatment of KRAS-mutant cancers

Current therapy of KRAS-mutant lung cancer

A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers

Hochschulschrift

Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression

Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Target Mutant KRAS with Molecular Glue

K-Ras protein as a drug target

Unraveling (K)RAS in pancreatic ductal adenocarcinoma

A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

A pan-KRAS degrader for the treatment of KRAS-mutant cancers

Current therapy of KRAS-mutant lung cancer

A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers

Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer

Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression

Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Target Mutant KRAS with Molecular Glue

K-Ras protein as a drug target

Unraveling (K)RAS in pancreatic ductal adenocarcinoma

A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

A pan-KRAS degrader for the treatment of KRAS-mutant cancers

Current therapy of KRAS-mutant lung cancer

A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers

Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer

Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression

Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Target Mutant KRAS with Molecular Glue

K-Ras protein as a drug target

Unraveling (K)RAS in pancreatic ductal adenocarcinoma

A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

A pan-KRAS degrader for the treatment of KRAS-mutant cancers

Current therapy of KRAS-mutant lung cancer

A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers

Targeting ErbB receptors in a three-dimensional cell culture model of K-Ras mutant colorectal cancer

Related objects

Reset password